Langerhans Cell Histiocytosis

Explore clinical trials studying Langerhans Cell Histiocytosis. Study availability and eligibility vary by location and protocol.

17 public trials 5 recruiting studies

Refine in advanced search Browse all conditions

Langerhans Cell Histiocytosis trial results

Completed

Denosumab for the Treatment of Adult LCH

NCT03270020

Conditions: Hemic and Lymphatic Diseases, Histiocytosis, Histiocytosis, Langerhans-Cell, +5 more
Locations: 251 Hellenic AirForce & VA General Hospital, Dpt of Endocrinology Athens, Attica, Greece

View Trial Details

Completed

Umbilical Cord Blood Transplant With Added Sugar and Chemotherapy and Radiation Therapy in Treating Patients With Leukemia or Lymphoma

NCT03096782

Conditions: Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Biphenotypic Leukemia, Acute Leukemia, +59 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

A Study to Test the Ability of and Safety of GSK2110183 in Treating Langerhans Cell Histiocytosis

NCT01395004

Conditions: Hemic and Lymphatic Diseases, Histiocytosis, Histiocytosis, Langerhans-Cell, +5 more
Locations: Johns Hopkins Hospital Baltimore, Maryland, United States

Dana Farber Cancer Institute Boston, Massachusetts, United States

Memorial Sloan Kettering Cancer Center New York, United States

Staten Island University Hospital Staten Island, New York, United States

View Trial Details

Completed

Evaluation of Exercise Capacity and Exercise Limitation in Patients With Pulmonary Langerhans Cell Histiocytosis

NCT02665546

Conditions: Cardiovascular Diseases, Dyspnea, Hemic and Lymphatic Diseases, +14 more
Locations: InCor Heart Institute São Paulo, Brazil

View Trial Details

Completed

Methotrexate and Cytosine in Adult Langerhans Cell Histiocytosis

NCT02389400

Conditions: Hemic and Lymphatic Diseases, Histiocytosis, Histiocytosis, Langerhans-Cell, +5 more
Locations: Peking union medical college hospital Beijing, China

View Trial Details

Completed

Uptake and Biodistribution of 18F-fluorocholine in Histiocytic Disorders by PET Imaging and Biopsy Measurement

NCT02608619

Conditions: Erdheim-Chester Disease, Hemic and Lymphatic Diseases, Histiocytic Disorders, +8 more
Locations: Memoral Sloan Kettering Cancer Center New York, United States

View Trial Details

Completed

Study of Sequential Administration of Oral 6-Thioguanine After Methotrexate in Patients With LCH

NCT00588536

Conditions: Hemic and Lymphatic Diseases, Histiocytosis, Histiocytosis, Langerhans-Cell, +5 more
Locations: Memorial Sloan-Kettering Cancer Center New York, United States

View Trial Details

Langerhans Cell Histiocytosis

Langerhans Cell Histiocytosis trial results

Denosumab for the Treatment of Adult LCH

Umbilical Cord Blood Transplant With Added Sugar and Chemotherapy and Radiation Therapy in Treating Patients With Leukemia or Lymphoma

A Study to Test the Ability of and Safety of GSK2110183 in Treating Langerhans Cell Histiocytosis

Evaluation of Exercise Capacity and Exercise Limitation in Patients With Pulmonary Langerhans Cell Histiocytosis

Methotrexate and Cytosine in Adult Langerhans Cell Histiocytosis

Uptake and Biodistribution of 18F-fluorocholine in Histiocytic Disorders by PET Imaging and Biopsy Measurement

Study of Sequential Administration of Oral 6-Thioguanine After Methotrexate in Patients With LCH

Related conditions